Niva Bupa Health Insurance Company
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Niva Bupa Health Insurance Company is positioned for robust growth, driven by management's strategic pivot towards higher-margin retail health products and a strong operational performance. Recent earnings calls highlight a significant 27.4% growth in gross written premium (GWP) and an 80% year-over-year increase in profit after tax (PAT), underscoring the company's effective claims management and disciplined underwriting practices. Management's focus on expanding distribution channels, particularly in Tier-2 and Tier-3 markets, aligns with the broader industry trend of increasing insurance penetration in India. Vista's financial outlook reflects this momentum, projecting accelerated revenue growth and improving margins, supported by a stable balance sheet and a premium valuation. The anticipated CAGR of 24% in IFRS insurance revenue and 28% in PAT over the next two years reinforces the positive trajectory. However, potential regulatory changes and competitive pressures remain watchpoints. Overall, Niva Bupa's strategic initiatives and favorable market conditions position it well for sustained growth, with a target price of INR 168.37 for the next 12 months and INR 331.62 for 24 months
Why We Like This Stock
- Strong operational performance with a 27.4% GWP growth and 80% YoY PAT increase
- Strategic focus on higher-margin retail health products and expansion into underpenetrated markets
- Positive industry dynamics with improving pricing power and structural tailwinds supporting growth
Things To Watch Out For
- Potential regulatory changes regarding expense ratios could impact profitability
- Intense competition in the health insurance sector may challenge market share gains
- Seasonal claims volatility poses risks to earnings stability
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 4,115 | 5,374 | 6,695 | 9,088 | 11,186 |
| Profit Before Tax (Cr.) | 79 | 209 | 127 | 960 | 918 |
| PBT Margin | 1.9% | 3.9% | 189.7% | 10.6% | 8.2% |
| Net Profit (Cr.) | 79 | 209 | 131 | 720 | 688 |
| Earnings Per Share | 0.4 | 1.1 | 0.7 | 3.9 | 3.7 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Morgan Stanley | ► Equalweight | 91 | 31-Jul-2026 |
| Motilal Oswal | ▲ Buy | 103 | 31-Jul-2026 |
| Nomura | ▲ Buy | 105 | 30-Jun-2026 |
Company Overview
Show Company Profile
Niva Bupa Health Insurance Company Limited provides health insurance products in India. It offers health insurance plans, such as individual, family, NRIs, senior citizens, personal accident, critical illness; travel insurance, including international and studying abroad insurance plans; and corporate insurance comprising group and start up health, group personal accident and OPD coverage, and group health insurance claim process. The company was formerly known as Max Bupa Health Insurance Company Limited and changed its name to Niva Bupa Health Insurance Company Limited in July 2021. The company was founded in 1947 and is based in Gurugram, India. Niva Bupa Health Insurance Company Limited is a subsidiary of Bupa Singapore Holdings Pte. Ltd.